{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T06:03:17Z","timestamp":1760853797861},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.ejphar.2014.10.045","type":"journal-article","created":{"date-parts":[[2014,11,6]],"date-time":"2014-11-06T16:35:01Z","timestamp":1415291701000},"page":"217-222","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Effect of AS2521780, a novel PKC\u03b8 selective inhibitor, on T cell-mediated immunity"],"prefix":"10.1016","volume":"745","author":[{"given":"Hidehiko","family":"Fukahori","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noboru","family":"Chida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mamoru","family":"Tasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Kawashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideaki","family":"Matsuoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiko","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuyuki","family":"Higashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2014.10.045_bib1","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1093\/oxfordjournals.jbchem.a003296","article-title":"Protein kinase C-epsilon (PKC-epsilon): its unique structure and function","volume":"132","author":"Akita","year":"2002","journal-title":"J. Biochem."},{"key":"10.1016\/j.ejphar.2014.10.045_bib2","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1128\/MCB.16.4.1842","article-title":"Protein kinase C-theta isoenzyme selective stimulation of the transcription factor complex AP-1 in T lymphocytes","volume":"16","author":"Baier-Bitterlich","year":"1996","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ejphar.2014.10.045_bib3","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1034\/j.1600-065X.2003.00018.x","article-title":"The PKC gene module: molecular biosystematics to resolve its T cell functions","volume":"192","author":"Baier","year":"2003","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.ejphar.2014.10.045_bib4","doi-asserted-by":"crossref","first-page":"4997","DOI":"10.1016\/S0021-9258(18)53494-3","article-title":"Molecular cloning and characterization of PKC theta, a novel member of the protein kinase C (PKC) gene family expressed predominantly in hematopoietic cells","volume":"268","author":"Baier","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2014.10.045_bib5","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/TP.0b013e31823cf92f","article-title":"Sotrastaurin (AEB071) alone and in combination with cyclosporine A prolongs survival times of non-human primate recipients of life-supporting kidney allografts","volume":"93","author":"Bigaud","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.ejphar.2014.10.045_bib6","doi-asserted-by":"crossref","first-page":"14208","DOI":"10.1016\/S0021-9258(19)85228-6","article-title":"Molecular cloning and expression of a cDNA encoding a novel isoenzyme of protein kinase C (nPKC). A new member of the nPKC family expressed in skeletal muscle, megakaryoblastic cells, and platelets","volume":"268","author":"Chang","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2014.10.045_bib7","doi-asserted-by":"crossref","first-page":"333","DOI":"10.5414\/CNP73333","article-title":"Novel immunosuppressive agents in kidney transplantation","volume":"73","author":"Cooper","year":"2010","journal-title":"Clin. Nephrol."},{"key":"10.1016\/j.ejphar.2014.10.045_bib8","first-page":"3394","article-title":"NF-kappa B activation induced by T cell receptor\/CD28 costimulation is mediated by protein kinase C-theta","volume":"97","author":"Coudronniere","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejphar.2014.10.045_bib9","doi-asserted-by":"crossref","first-page":"24547","DOI":"10.1074\/jbc.C000177200","article-title":"Synergistic activation of NF-kappa B by functional cooperation between vav and PKCtheta in T lymphocytes","volume":"275","author":"Dienz","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2014.10.045_bib10","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1124\/jpet.109.153205","article-title":"The potent protein kinase C-selective inhibitor AEB071 (sotrastaurin) represents a new class of immunosuppressive agents affecting early T-cell activation","volume":"330","author":"Evenou","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2014.10.045_bib11","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1016\/j.jss.2011.06.039","article-title":"The effects of AEB071 (sotrastaurin) with tacrolimus on rat heterotopic cardiac allograft rejection and survival","volume":"171","author":"Fang","year":"2011","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.ejphar.2014.10.045_bib12","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1016\/j.molimm.2009.02.030","article-title":"PKC theta cooperates with PKC alpha in alloimmune responses of T cells in vivo","volume":"46","author":"Gruber","year":"2009","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.ejphar.2014.10.045_bib13","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.4049\/jimmunol.177.3.1886","article-title":"PKC-theta-deficient mice are protected from Th1-dependent antigen-induced arthritis","volume":"177","author":"Healy","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2014.10.045_bib14","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.it.2012.11.003","article-title":"The where and when of T cell regulation in transplantation","volume":"34","author":"Issa","year":"2013","journal-title":"Trends Immunol."},{"key":"10.1016\/j.ejphar.2014.10.045_bib15","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.tips.2009.10.006","article-title":"Protein kinase Calpha: disease regulator and therapeutic target","volume":"31","author":"Konopatskaya","year":"2010","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2014.10.045_bib16","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1128\/MCB.20.8.2933-2940.2000","article-title":"Protein kinase C-theta participates in NF-kappaB activation induced by CD3\u2013CD28 costimulation through selective activation of IkappaB kinase beta","volume":"20","author":"Lin","year":"2000","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ejphar.2014.10.045_bib17","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/s00011-004-1294-9","article-title":"Comparison of anti-arthritic properties of leflunomide with methotrexate and FK506: effect on T cell activation-induced inflammatory cytokine production in vitro and rat adjuvant-induced arthritis","volume":"53","author":"Magari","year":"2004","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.ejphar.2014.10.045_bib18","doi-asserted-by":"crossref","first-page":"513","DOI":"10.4049\/jimmunol.181.1.513","article-title":"A critical role for protein kinase C-theta-mediated T cell survival in cardiac allograft rejection","volume":"181","author":"Manicassamy","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2014.10.045_bib19","doi-asserted-by":"crossref","first-page":"6004","DOI":"10.4049\/jimmunol.176.10.6004","article-title":"Defective IgG2a\/2b class switching in PKC alpha\u2212\/\u2212 mice","volume":"176","author":"Pfeifhofer","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2014.10.045_bib20","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1084\/jem.20020234","article-title":"Protein kinase C theta affects Ca2+ mobilization and NFAT cell activation in primary mouse T cells","volume":"197","author":"Pfeifhofer","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ejphar.2014.10.045_bib21","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1006\/clin.1996.0118","article-title":"Th1 and Th2 in human diseases","volume":"80","author":"Romagnani","year":"1996","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.ejphar.2014.10.045_bib22","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1111\/ajt.12251","article-title":"Efficacy of sotrastaurin plus tacrolimus after de novo kidney transplantation: randomized, phase II trial results","volume":"13","author":"Russ","year":"2013","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.ejphar.2014.10.045_bib23","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/PL00000227","article-title":"FK506 is superior to methotrexate in therapeutic effects on advanced stage of rat adjuvant-induced arthritis","volume":"50","author":"Sakuma","year":"2001","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.ejphar.2014.10.045_bib24","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/ni1097","article-title":"Protein kinase C and beyond","volume":"5","author":"Spitaler","year":"2004","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ejphar.2014.10.045_bib25","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/35006090","article-title":"PKC-theta is required for TCR-induced NF-kappaB activation in mature but not immature T lymphocytes","volume":"404","author":"Sun","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2014.10.045_bib26","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1042\/bj20031406","article-title":"Emerging and diverse roles of protein kinase C in immune cell signalling","volume":"376","author":"Tan","year":"2003","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejphar.2014.10.045_bib27","unstructured":"Tanaka, A., Mukoyoshi, K., Kunikawa, S., Takasuna, Y., Nagashima, S., Chida, N., Ohkubo, M., Ohta, M., Takeuchi, M., 2013. Discovery of AS2521780, a novel, potent, selective PKC\u03b8 inhibitor as an immunosuppressive agent. In: Proceedings of the 245th ACS National Meeting and Exposition MEDI-47."},{"key":"10.1016\/j.ejphar.2014.10.045_bib28","doi-asserted-by":"crossref","first-page":"3774","DOI":"10.1172\/JCI39692","article-title":"PKCtheta is required for alloreactivity and GVHD but not for immune responses toward leukemia and infection in mice","volume":"119","author":"Valenzuela","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2014.10.045_bib29","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/j.1432-2277.2009.01015.x","article-title":"Effects of the novel protein kinase C inhibitor AEB071 (Sotrastaurin) on rat cardiac allograft survival using single agent treatment or combination therapy with cyclosporine, everolimus or FTY720","volume":"23","author":"Weckbecker","year":"2010","journal-title":"Transpl. Int."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299914007523?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299914007523?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T15:21:16Z","timestamp":1650554476000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299914007523"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":29,"alternative-id":["S0014299914007523"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2014.10.045","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of AS2521780, a novel PKC\u03b8 selective inhibitor, on T cell-mediated immunity","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2014.10.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}